Literature DB >> 7043751

Sulfadoxine-pyrimethamine resistant falciparum malaria in Thai children.

T Chongsuphajaisiddhi, A Sabchareon.   

Abstract

Sixty-eight children with uncomplicated falciparum malaria admitted to the Hospital for Tropical Diseases in Bangkok during April-December 1980 were randomly divided into 3 groups and given 3 regimens. Group 1 of 27 cases were treated with a single dose of sulfadoxine 20 mg per kg body wt and pyrimethamine 1.0 mg per kg body wt. Two cases (7.4%) were cured (S) while 4 cases (14.8%) showed RI failure, 17 cases (63.0%) RII failure and 4 cases (14.8) RIII failure. In Group 2, 18 cases were treated with a single dose of sulfadoxine 30 mg per kg body wt and pyrimethamine 1.5 mg per kg body wt. Two cases (11.1%) were cured (S), while 7 cases (38.9%) showed RI failure, 7 cases (38.9%) RII failure and 2 cases (11.1%) RIII failure. In Group 3, 23 cases were treated with quinine 10 mg base per kg body wt 8 hourly for 5 days plus sulfadoxine 20 mg per kg body wt and pyrimethamine 1.0 mg per kg body wt, single dose given with the last dose of quinine. Thirteen cases (56.5%) were cured (S), while 10 cases (43.5%) showed RI failure.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7043751

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  8 in total

Review 1.  Origin and Spread of Evolving Artemisinin-Resistant Plasmodium falciparum Malarial Parasites in Southeast Asia.

Authors:  Matthew R Hassett; Paul D Roepe
Journal:  Am J Trop Med Hyg       Date:  2019-12       Impact factor: 2.345

2.  Evaluation of an in vitro test method for the assessment of sensitivity of Plasmodium falciparum to pyrimethamine and sulfadoxine.

Authors:  A Sabchareon; T Chongsuphajaisiddhi; P Attanath; B Meemanee; W Wernsdorfer
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

3.  Tracking origins and spread of sulfadoxine-resistant Plasmodium falciparum dhps alleles in Thailand.

Authors:  Md Tauqeer Alam; Sumiti Vinayak; Kanungnit Congpuong; Chansuda Wongsrichanalai; Wichai Satimai; Laurence Slutsker; Ananias A Escalante; John W Barnwell; Venkatachalam Udhayakumar
Journal:  Antimicrob Agents Chemother       Date:  2010-10-18       Impact factor: 5.191

4.  In vitro susceptibility of Plasmodium falciparum collected from pyrimethamine-sulfadoxine sensitive and resistant areas in Thailand.

Authors:  A Sabchareon; T Chongsuphajaisiddhi; P Attanath; K Kanjanapipatkul; E B Doberstyn; L Suebsaeng
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

5.  A phase-III clinical trial of mefloquine in children with chloroquine-resistant falciparum malaria in Thailand.

Authors:  T Chongsuphajaisiddhi; A Sabchareon; P Chantavanich; V Singhasivanon; P Attanath; W H Wernsdorfer; U K Sheth
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

6.  Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.

Authors:  Rachael Milligan; André Daher; Patricia M Graves
Journal:  Cochrane Database Syst Rev       Date:  2019-07-05

7.  Efficacy of Pyrimethamine/Sulfadoxine versus Chloroquine for the Treatment of Uncomplicated Falciparum Malaria in Children Aged Under 5 Years.

Authors:  W Zheng; H Jiang; Z Xiong; Z Jiang; H Chen
Journal:  Iran J Parasitol       Date:  2013-01       Impact factor: 1.012

8.  Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India.

Authors:  Neelima Mishra; Kamlesh Kaitholia; Bina Srivastava; Naman K Shah; Jai Prakash Narayan; Vas Dev; Sobhan Phookan; Anupkumar R Anvikar; Roma Rana; Ram Suresh Bharti; Gagan Singh Sonal; Akshay Chand Dhariwal; Neena Valecha
Journal:  Malar J       Date:  2014-07-22       Impact factor: 2.979

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.